US$ 29.07
retatrutide parkinson parkinson's clinical trial Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed retatrutide parkinson clinical trial π
Description
While this is fantastic for weight loss, it's important to understand the full picture
PMID: 30367901

Bottom line: Oral GLP-1 is expanding the categorybut injections still set the performance standard

This is about the same price as 4, 0.75 mL of 2.4 mg/0.75 mL pens of Wegovy, but around $300 more expensive than 4, 0.5 mL of 5 mg/0.5 mL pens of Zepbound (tirzepatide)
The participants received weekly 2-milligram injections for six weeks, and the results were encouraging
